How a claim degrades between the bench and the listing
The Journal does not treat a badge as evidence and states so wherever it reports one.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 19 of 33 of this archive, newest first.
The Journal does not treat a badge as evidence and states so wherever it reports one.
A proper account of an operation that existed, and of what closing it cost.
Reported from the analysis, not from a warning notice.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
A proper account of an operation that existed, and of what closing it cost.
A proper account of an operation that existed, and of what closing it cost.
A proper account of an operation that existed, and of what closing it cost.
Reported from the analysis, not from a warning notice.
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
A proper account of an operation that existed, and of what closing it cost.
Reported from the analysis, not from a warning notice.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
A proper account of an operation that existed, and of what closing it cost.
Reported from the analysis, not from a warning notice.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.